what states have banned semaglutide Medicare is expanding access to weight-loss GLP-1 medications. Starting July 1, eligible Medicare beneficiaries can receive GLP-1 prescriptions for obesity for $50 a month through a new federal pilot program, even without Ozempic, Wegovy-maker hires lobbying firm

Jan 22, 2026 Semaglutide and Heart Risk: What the Research Shows Can Ozempic (semaglutide) reduce cardiovascular risk

Heartburn and gastroesophageal reflux disease (GERD)

Losing weight with the help of Semaglutide may lead to better mobility, allowing you to engage more fully in what you enjoy doing

Quick Answer: Semaglutide is FDA-approved for chronic weight management without a specified maximum treatment duration, and patients may continue therapy indefinitely as long as they respond well and tolerate the medication

El ipamorelin acta sobre los receptores de la ghrelina, una hormona que regula el apetito y la energa

Whether youre managing weight with Semaglutide or exploring other wellness treatments, we are here to support you every step of the way